Korsana Biosciences has emerged from stealth with US$175m to develop an Alzheimer’s antibody designed to boost amyloid plaque clearance. The Waltham, Massachusetts-based biotech is focused on...
GSK has signed a five-year deal with JAX-NYSCF to build stem cell models for neurodegenerative disease, with Alzheimer’s a key target. The collaboration with The Jackson...
Long-term gut health and female finance, London likes longevity New York innovator Salvo Health has secured $8.5m in Series A round as it looks to develop...
Bryan Johnson has launched a US$1m-a-year longevity programme with just three places, offering access to the exact protocol he has followed for five years. The programme,...
A French biotech has raised €12m to test whether GLP-1 drugs can modify osteoarthritis progression. The funding will advance 4Moving Biotech’s lead programme, 4P004, toward a...
Harbor Health has acquired dementia care startup Rippl; terms were not disclosed. Founded in 2021, Rippl provides specialised dementia care and support, including personalised care plans,...
Longevity startup Biopeak has secured US$2.7m in a follow-on funding round. Founded in 2025 by Rishi Pardal and Shiva Subramanian, Biopeak operates India’s first specialised brand...
